Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crohn Disease
|
1147 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 1.000 | 0.949 | 78 | 2001 | 2019 | |||||
Ulcerative Colitis
|
827 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.800 | 0.846 | 13 | 2002 | 2018 | |||||
Yao syndrome
|
3 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.800 | 1.000 | 2 | 2011 | 2015 | |||||
Ankylosing spondylitis
|
609 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.730 | 0.750 | 4 | 2002 | 2016 | |||||
SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)
|
22 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.710 | 1.000 | 9 | 2003 | 2011 | |||||
Psoriasis
|
705 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.710 | 1.000 | 2 | 2006 | 2016 | |||||
Regional enteritis
|
15 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.700 | 1.000 | 8 | 2003 | 2011 | |||||
Cholangitis, Sclerosing
|
276 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Inflammatory Bowel Diseases
|
605 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.100 | 1.000 | 11 | 2002 | 2017 | |||||
Colorectal Carcinoma
|
1962 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.060 | 0.833 | 6 | 2005 | 2014 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.040 | 0.750 | 4 | 2005 | 2008 | |||||
Sarcoidosis
|
787 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.040 | 0.750 | 4 | 2005 | 2018 | |||||
Arthritis, Psoriatic
|
89 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 1.000 | 3 | 2004 | 2010 | |||||
Familial (FPAH)
|
276 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 1.000 | 3 | 2003 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 0.667 | 3 | 2005 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 0.667 | 3 | 2005 | 2014 | |||||
Bronchiolitis Obliterans
|
5 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2008 | 2019 | |||||
Primary bacterial peritonitis
|
11 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||
Sepsis
|
144 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2007 | 2012 | |||||
Septicemia
|
141 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2007 | 2012 | |||||
Spondylarthritis
|
23 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2002 | 2005 | |||||
Tuberculosis
|
328 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Acute Inflammatory Demyelinating Polyneuropathy
|
2 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Acute Motor Axonal Neuropathy
|
4 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Acute motor sensory axonal neuropathy
|
2 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2016 | 2016 |